Advertisement

Advertisement

Announcements

John E. Dick, PhD, FAACR, to Receive Inaugural AACR Award for Outstanding Achievement in Blood Cancer Research

The ASCO Post Staff  /  May 25, 2022

The American Association for Cancer Research (AACR) announced that John E. Dick, PhD, FAACR, Canada Research Chair in Stem Cell Biology, Senior Scientist at the Princess Margaret Cancer Centre, University Health Network, and Professor in the Department of Molecular Genetics at the University of Tor...

MSK Introduces The Starr Foundation Program for Discovery Science

The ASCO Post Staff  /  May 10, 2022

Memorial Sloan Kettering Cancer Center (MSK) recently announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering initiative made possible by a $50 million gift from The Starr Foundation. The program will support the work of scientists at the Sloan Kettering Insti...

Memorial Sloan Kettering Announces Two New Appointments

The ASCO Post Staff  /  March 25, 2020

Memorial Sloan Kettering Cancer Center (MSK) recently appointed Sergio Giralt, MD, and Miguel-Angel Perales, MD, as Deputy Division Head of the Division of Hematologic Malignancies and Chief of the Adult Bone Marrow Transplant Service, respectively. Dr. Giralt: New Roles and Old Former Chief of th...

New England Cancer Specialists to Become Affiliate Member of Dana-Farber Cancer Institute

The ASCO Post Staff  /  May 25, 2022

New England Cancer Specialists has recently become an Affiliate Member of the Dana-Farber Cancer Institute. Affiliate Membership reflects a demonstrated commitment to excellence by meeting a wide array of standards and best practices in oncology care. Although New England Cancer Specialists is the f...

Children’s Hospital of Philadelphia Establishes the Susan S. and Stephen P. Kelly Center for Cancer Immunotherapy

The ASCO Post Staff  /  May 25, 2022

Children’s Hospital of Philadelphia (CHOP) announced it has received a significant gift from Susan and Steve Kelly, local philanthropists and long-time supporters of CHOP, to establish the Susan S. and Stephen P. Kelly Center for Cancer Immunotherapy. The new Center, led by Stephan Grupp, MD, PhD, w...

Perlmutter Cancer Center Appoints Inaugural Director of Center for Blood Cancers

The ASCO Post Staff  /  May 25, 2022

Faith E. Davies, MD, a nationally renowned hematology expert, has been appointed the inaugural Director of the Center for Blood Cancers at NYU Langone Health’s Perlmutter Cancer Center. Dr. Davies currently serves as Professor in the Department of Medicine at NYU Grossman School of Medicine and Dir...

Elaine S. Jaffe, MD, Honored With Inaugural AACR James S. Ewing– Thelma B. Dunn Award for Outstanding Achievement in Pathology

The ASCO Post Staff  /  May 25, 2022

At the recent American Association for Cancer Research (AACR) Annual Meeting 2022, Elaine S. Jaffe, MD, received the inaugural AACR James S. Ewing–Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research. The AACR established this new award to honor pathologists who continue ...

Steven A. Rosenberg, MD, PhD, Recognized With 2022 Pezcoller Foundation–AACR International Award

The ASCO Post Staff  /  May 25, 2022

The Pezcoller Foundation–American Association for Cancer Research (AACR) International Award for Extraordinary Achievement in Cancer Research was presented to Steven A. Rosenberg, MD, PhD, at the Association’s 2022 Annual Meeting, held in New Orleans. Dr. Rosenberg was honored for his discovery and ...

UC Davis Launches Center for Advancing Cancer Health Equity

The ASCO Post Staff  /  May 25, 2022

To address cancer health disparities in the region, the University of California (UC) Davis Comprehensive Cancer Center is launching the Center for Advancing Cancer Health Equity, which will conduct community-engaged research and interventions using multilevel approaches. The new center will build o...

Diversity in Clinical Trials Training Program Renamed to Honor Robert A. Winn, MD

The ASCO Post Staff  /  May 25, 2022

The Bristol Myers Squibb Foundation (BMSF), together with its partners National Medical Fellowships and the American Association for Cancer Research, has announced a new name for the $100 million, 5-year initiative launched in 2020 to increase diversity in clinical trials: The Robert A. Winn Diversi...

NCCN Announces Indiana University Melvin and Bren Simon Comprehensive Cancer Center Joins Member Institutions

The ASCO Post Staff  /  May 10, 2022

The National Comprehensive Cancer Network® (NCCN®) recently announced that Indiana University Melvin and Bren Simon Comprehensive Cancer Center has joined the not-for-profit alliance of leading cancer centers as the 32nd member institution. NCCN was founded by 13 original Member Institutions in 1995...

Penn Medicine Appoints Robert Vonderheide, MD, DPhil, to Second 5-Year Term as Director of Abramson Cancer Center

The ASCO Post Staff  /  May 10, 2022

Robert H. Vonderheide, MD, DPhil, has been appointed to a second 5-year term as Director of the Abramson Cancer Center (ACC) at the University of Pennsylvania, following a highly successful tenure that saw 17 U.S. Food and Drug Administration approvals in oncology for therapies based on studies le...

David Braun, MD, PhD, Joins Prostate and Urologic Cancers Program at Yale Cancer Center

The ASCO Post Staff  /  May 10, 2022

Yale Cancer Center and Smilow Cancer Hospital welcome David Braun, MD, PhD, Assistant Professor of Medicine (Medical Oncology) and a member of the Center for Molecular and Cellular Oncology (CMCO). Dr. Braun cares for patients with kidney cancer. Dr. Braun received his PhD in Computational Biolog...

Sam Mbulaiteye, MBChB, MPhil, MMed, Named 2022 Scientist of the Year by Lymphoma Foundation of America

The ASCO Post Staff  /  May 10, 2022

Sam Mbulaiteye, MBChB, MPhil, MMed, senior investigator in the Infections and Immunoepidemiology Branch, in the Division of Cancer Epidemiology & Genetics of the National Cancer Institute, was recently recognized by the Lymphoma Foundation of America with its 2022 Scientist of the Year Award. ...

J. Paul Taylor, MD, PhD, Named Scientific Director and Executive Vice President of St. Jude

The ASCO Post Staff  /  May 10, 2022

J. Paul Taylor, MD, PhD, has been named Scientific Director and Executive Vice President of St. Jude Children’s Research Hospital. Dr. Taylor steps into the role during a pivotal time of growth for the hospital. Under its $11.5 billion, 6-year strategic plan, the institution’s scientific enterpris...

AACR Honors Lee Ellis, MD, for Contributions to Education and Training in Cancer Research

The ASCO Post Staff  /  May 10, 2022

The American Association for Cancer Research (AACR) has named Lee Ellis, MD, Professor of Colon and Rectal Surgery at The University of Texas MD Anderson Cancer Center, Houston, as the 2022 recipient of the AACR Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Ca...

National Brain Tumor Society Launches DNA Damage Response Consortium With Yale Cancer Center

The ASCO Post Staff  /  April 10, 2022

The National Brain Tumor Society (NBTS) announced the launch of its new flagship research initiative, the DNA Damage Response Consortium, in partnership with Yale Cancer Center. The consortium will bring together a diverse team of adult and pediatric researchers to advance a new class of potential t...

St. Jude Receives First Group of Ukrainian Children With Cancer for Care in the United States

Jo Cavallo  /  April 25, 2022

One month after Russia invaded Ukraine, on March 21, St. Jude Children’s Research Hospital in Memphis welcomed four Ukrainian children with cancer to be treated in the United States. Two of the children are pictured in the photos below. The four children, aged 20 months to 8 years old, traveled to t...

Tony Hunter, PhD, FAACR, Honored With 2022 AACR Award for Lifetime Achievement in Cancer Research

The ASCO Post Staff  /  April 25, 2022

The American Association for Cancer Research (AACR) awarded the 2022 AACR Award for Lifetime Achievement in Cancer Research to Tony Hunter, PhD, FAACR, Fellow of the AACR Academy, at its Annual Meeting in New Orleans. Dr. Hunter is the American Cancer Society Professor and Renato Dulbecco Chair a...

Philip D. Greenberg, MD, FAACR, Voted AACR President-Elect for 2022–2023

The ASCO Post Staff  /  April 25, 2022

The members of the American Association for Cancer Research (AACR) have chosen Philip D. Greenberg, MD, FAACR, as the Association’s President-Elect for 2022–2023. Dr. Greenberg is the Rona Jaffe Foundation Endowed Chair and Professor and Head of the Program in Immunology, Clinical Research Divisio...

Norman Sharpless, MD, to Step Down as Director of the NCI

The ASCO Post Staff  /  April 25, 2022

Norman E. Sharpless, MD, has announced that he has decided to step down from his position as Director of the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), a position he has held since 2017. Dr. Sharpless will continue as NCI Director through April 29, 2022, to...

Andrew Chapman, DO, FACP, Appointed Director of the Sidney Kimmel Cancer Center–Jefferson Health, Philadelphia

The ASCO Post Staff  /  April 25, 2022

Andrew Chapman, DO, FACP, has been named Director of the Sidney Kimmel Cancer Center–Jefferson Health, with locations in Philadelphia and nearby areas in Pennsylvania and New Jersey. He has also been named the Center’s Executive Vice President for Oncology Services. He has served as the Center’s I...

Fox Chase Cancer Center Appoints Elizabeth Plimack, MD, MS, as Deputy Director

The ASCO Post Staff  /  April 25, 2022

Elizabeth Plimack, MD, MS, has been appointed to Deputy Director at Fox Chase Cancer Center in Philadelphia, according to Jonathan Chernoff, MD, PhD, Cancer Center Director at Fox Chase. Dr. Plimack is Chief of the Division of Genitourinary Medical Oncology and Professor in the Department of Hem...

Improving Oral Anticancer Therapy Adherence, a Call to Action, and an Upcoming FDA-ASCO Workshop

The ASCO Post Staff  /  April 10, 2022

In a recently published paper in the Journal of Clinical Oncology,1 R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, of Emory University, Atlanta, and coleagues reflected on the growth in availability of oral anticancer therapies over the past decade and noted that as these treatments are easy to take...

AACR and MPM Oncology Charitable Foundation Announce Three Grants to Support Transformative Cancer Research

The ASCO Post Staff  /  April 10, 2022

Three grants for research that could transform cancer therapies have been awarded by the AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants Program, an innovative partnership between the American Association for Cancer Research (AACR) and the UBS Oncology Impact Fund (OIF)...

Jeffrey Peppercorn, MD, MPH, Named Editor-in-Chief of JCO Oncology Practice

The ASCO Post Staff  /  April 10, 2022

Jeffrey Peppercorn, MD, MPH, has been appointed as the next Editor-in-Chief of the ASCO journal JCO Oncology Practice (JCO OP). The journal publishes impactful information and insights to keep oncology practice current on changes and challenges inherent in delivering equitable, high-quality oncology...

Seven New Research Grants Awarded by The Prevent Cancer Foundation

The ASCO Post Staff  /  April 10, 2022

The Prevent Cancer Foundation recently announced funding for seven scientists who are researching cancer prevention and early detection. Each scientist has been awarded $100,000 for 2 years. The following individuals are the 2022 research grantees: Sarah Bernhardt, PhD, Postdoctoral Fellow Oregon...

City of Hope Completes Strategic Acquisition of Cancer Treatment Centers of America

The ASCO Post Staff  /  April 10, 2022

On February 2, 2022, City of Hope announced that it has completed its previously announced acquisition of Cancer Treatment Centers of America (CTCA), a network of oncology hospitals and outpatient care centers across the United States. City of Hope, in Duarte, California, now has expanded its geogra...

The Hamoui Foundation and LUNGevity Foundation Present Awards for RET-Positive Lung Cancer Research

The ASCO Post Staff  /  April 10, 2022

The Hamoui Foundation and LUNGevity Foundation recently announced the 2022 recipients of the first The Hamoui Foundation/LUNGevity Clinical Research Award for RET-Positive Lung Cancer. RET is a driver mutation found in approximately 1% to 2% of people with non–small cell lung cancer. The goal of the...

American Cancer Society Awards $16 Million in Grants to Establish Cancer Health Equity Research Centers

The ASCO Post Staff  /  April 10, 2022

The American Cancer Society has awarded more than $16 million in grants to establish Cancer Health Equity Research Centers (CHERC) at minority-serving institutions. The inaugural cohort of institutions includes the Arizona Board of Regents–University of Arizona, the University of Illinois at Chicago...

ACCC Welcomes Matt Devino, MPH, as Director, Cancer Care Delivery and Health Policy

The ASCO Post Staff  /  March 25, 2022

The Association of Community Cancer Centers (ACCC) announced that Matt ­Devino, MPH, has joined the organization as Director, Cancer Care Delivery and Health Policy. Mr. Devino will lead the organization’s initiatives to improve cancer care delivery and promote health equity across rural, urban, a...

American Cancer Society Names Arif Kamal, MD, First Chief Patient Officer

The ASCO Post Staff  /  March 25, 2022

The American Cancer Society (ACS) has named Arif Kamal, MD, MBA, MHS, FACP, ­FAAHPM, FASCO, as its first Chief Patient Officer to lead its patient support vision and strategic plans to improve the lives of patients with cancer and their families. Based in Chapel Hill, North Carolina, Dr. Kamal will ...

New Role for Raymond N. DuBois, MD, PhD, FAACR, at The Mark Foundation for Cancer Research

The ASCO Post Staff  /  March 25, 2022

Raymond N. DuBois, MD, PhD, FAACR, was recently appointed Executive Chairman of the Board of The Mark Foundation for Cancer Research. Dr. DuBois is Director of the Medical University of South Carolina (MUSC) Hollings Cancer Center and Distinguished University Professor at MUSC. As The Mark Foundatio...

Robert Otto Valdez, PhD, MHSA, Named Director of the AHRQ

The ASCO Post Staff  /  March 25, 2022

Robert Otto Valdez, PhD, MHSA, was appointed Director of the Agency for Healthcare Research and Quality (AHRQ) in February 2022. He was previously the Robert Wood Johnson Foundation (RWJF) Professor Emeritus of Family & Community Medicine and Economics at the University of New Mexico (UNM). In 2...

ACCC Appoints David R. Penberthy, MD, MBA, as New President

The ASCO Post Staff  /  March 25, 2022

David R. Penberthy, MD, MBA, was recently named President of the Association of Community Cancer Centers (ACCC) at the organization’s 48th Annual Meeting and Cancer Center Business Summit. Oncology professionals from around the nation gathered at the conference to discuss the convergence of busine...

New Appointments for ECOG-ACRIN and NCI Committees

The ASCO Post Staff  /  March 25, 2022

Janice Mehnert, MD, was recently named Co-Chair of the ECOG-ACRIN Melanoma Committee, replacing Craig L. Slingluff, MD. Dr. Mehnert is Associate Director for Clinical Research and Director, Melanoma and Cutaneous Medical Oncology at NYU Langone’s Perlmutter Cancer Center. She specializes in both ski...

Arul Chinnaiyan, MD, PhD, Awarded Sjöberg Prize for Cancer Research

The ASCO Post Staff  /  March 25, 2022

The Royal Swedish Academy of Sciences, which also awards Nobel Prizes, has announced the winner of the 2022 Sjöberg Prize. Arul Chinnaiyan, MD, PhD, S.P. Hicks Professor of Pathology and Urology at Michigan Medicine, is being honored for the discovery of recurrent gene fusions in prostate cancer. Th...

B.J. Rimel, MD, Named Medical Director, Cancer Clinical Trials Office

The ASCO Post Staff  /  March 25, 2022

Gynecologic oncologist and surgeon B.J. Rimel, MD, recently was named Medical Director of the Cedars-Sinai Cancer Clinical Trials Office. She will serve as a medical liaison between clinical trial principal investigators and Cedars-Sinai Cancer leadership to ensure the quality of services provided t...

Bladder Cancer

Laura Bukavina, MD, MPH, Wins ASCO Genitourinary Conquer Cancer Merit Award for Microbiome Research in Bladder Cancer

The ASCO Post Staff  /  March 10, 2022

Laura Bukavina, MD, MPH, a Urologic oncology fellow at Fox Chase Cancer Center, has been awarded the ASCO Genitourinary Conquer Cancer Merit Award. She presented the winning abstract, which characterizes the gut microbiome of patients with bladder cancer, at the 2022 ASCO Genitourinary (GU) Cancers ...

OneOncology Names Davey Daniel, MD, Chief Medical Officer

The ASCO Post Staff  /  March 10, 2022

OneOncology, the national platform for independent community oncology practices, announced that Davey Daniel, MD, has been appointed Chief Medical Officer succeeding Lee Schwartzberg, MD. Dr. Schwartzberg served as the founding member of the platform’s clinical office and will remain a senior adviso...

Atul Gawande, MD, MPH, Appointed to Senior Post at U.S. Agency for International Development

The ASCO Post Staff  /  March 10, 2022

On December 17, 2021, the U.S. Senate confirmed President Joe Biden’s nomination of Atul Gawande, MD, MPH, as Assistant Administrator of Global Health Development at the U.S. Agency for International Development (USAID). Dr. Gawande assumed the new role in January 2022. Dr. Gawande’s role at USAI...

Hematologic Malignancies

Margaret von Mehren, MD, Appointed New Vice Chair of Department of Hematology/Oncology at Fox Chase

The ASCO Post Staff  /  March 10, 2022

Margaret von Mehren, MD, Chief of the Division of Sarcoma Medical Oncology at Fox Chase Cancer Center, was recently appointed the new Vice Chair of the Department of Hematology/Oncology. “It is an honor to serve the Department of Hematology and Oncology, which I have been a member of since 1993, wh...

Issues in Oncology

Linda Fleisher, PhD, MPH, Appointed Co-Chair of American Cancer Society’s National Navigation Roundtable

The ASCO Post Staff  /  March 10, 2022

Linda Fleisher, PhD, MPH, Associate Research Professor in the Cancer Prevention and Control research program at Fox Chase Cancer Center, was recently appointed Co-Chair of the American Cancer Society’s National Navigation Roundtable. Patient navigators act as intermediaries between patients and t...

Hematologic Malignancies

Iberia Romina Sosa, MD, PhD, Appointed New Chief of Division of Hematology at Fox Chase

The ASCO Post Staff  /  March 10, 2022

Iberia Romina Sosa, MD, PhD, Associate Professor at Fox Chase Cancer Center, was recently appointed as the new Chief of the Division of Hematology in the Department of Hematology/Oncology. “I feel truly privileged to have been offered this role and to have the opportunity to work with such a talent...

Memorial Sloan Kettering President and Chief Executive Officer, Craig B. Thompson, MD, to Step Down

The ASCO Post Staff  /  March 10, 2022

Craig B. Thompson, MD, announced his intention to step down as President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center (MSK) and has asked the Boards of Trustees and Governing Trustees to begin a search for his successor. Dr. Thompson will continue in his role until the Board...

Breast Cancer

American Cancer Society Reports Breast Cancer Is Now the Leading Cause of Cancer Mortality in Black Women

The ASCO Post Staff  /  March 10, 2022

Breast cancer has surpassed lung cancer as the leading cause of cancer mortality among Black women as of 2019. This news is one of the key findings in Cancer Statistics for African American/Black People 2022, published recently in CA: A Cancer Journal for Clinicians and its consumer-friendly compani...

Breast Cancer

Study Identifies Factors Impacting Adherence to Oral Medications for Metastatic Breast Cancer

The ASCO Post Staff  /  March 10, 2022

A recent study published by Conley et al in Breast Cancer Research and Treatment aimed to evaluate factors that influence the ability of people with metastatic breast cancer to adhere to their prescribed regimen of oral anticancer medication.1 Researchers found that multiple factors affected adheren...

Leukemia Committee of National Cooperative Clinical Trials Group Names New Co-Chairs

The ASCO Post Staff  /  March 10, 2022

A network sponsored by the National Cancer Institute, the Leukemia Committee of the Alliance for Clinical Trials in Oncology promotes collaboration between approximately 10,000 cancer specialists across the United States and Canada. The Committee recently announced the results of an international se...

CancerCare Offers Patients Financial Assistance for Transportation, Pet Care

The ASCO Post Staff  /  March 10, 2022

Financial assistance is available for some individuals with cancer from CancerCare, a nonprofit organization helping people cope with and manage the emotional and practical challenges of cancer. Financial assistance for transportation to and from treatment is available via CancerCare’s “Transportat...

NCI Office of Cancer Survivorship Welcomes Michelle Mollica, PhD, MPH, RN, OCN, as Senior Advisor

The ASCO Post Staff  /  March 10, 2022

Michelle Mollica, PhD, MPH, RN, OCN, has joined the National Cancer Institute (NCI) Office of Cancer Survivorship as Senior Advisor. In this role, she is responsible for developing, supporting, and promoting research efforts focused on cancer survivorship. Dr. Mollica also holds a secondary appoin...

Advertisement

Advertisement



Advertisement